Skip to main content

Q2 Solutions

US clinical research company Q2 Solutions has announced a multi-million pound inward investment at its Livingston campus, creating 156 skilled jobs over the next three years. Supported by a £3.8 million Scottish Enterprise grant, Q2 Solutions will establish a centre of excellence in flow cytometry and genomics testing and analysis, enabling it to offer an increased range of services to clients including leading pharmaceutical companies.

The Research and Development project will help anchor Q2 Solutions' operations in Scotland and sits alongside an ongoing £17m infrastructure expansion project at the campus, where the company already employs more than 950 people.  

The announcement follows confirmation this week that Scotland was the most popular UK location outside London for inward investment in 2020, for the sixth successive year. Elaine Lowey, Q2 Solutions' General Manager for Europe, the Middle East and Africa, said: “Expanding our European operations in key technical areas supporting the development of new precision medications adds significant value to our global pharmaceutical and biotechnology clients. We are delighted to be working with Scottish Enterprise in this venture and look forward to the job creation this will bring in our new state-of-the-art facility.”

Q2 Solutions was formed in 2015 and is a wholly-owned subsidiary of human data sciences company IQVIA, which employs a further 250 people at Livingston. It is the largest life science employer in Scotland, having grown its workforce by 28% in the last three years, and processes nearly 5 million biological samples from clinical trials across the world each year.

About the author

West Lothian Council

The West Lothian Council News Editor.

Back to top